Medicine 6 mins ago

US challenges ‘bogus' patents on Ozempic and other drugs in effort to spur competition

Federal regulators on Tuesday sent warning letters to several drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions.

Contact Us